Clinical Trials
19 trialsNCT02948543 2023-06-18
BCG+MM
University of Sydney
Phase 3 Unknown
NCT01675219 2023-04-13
Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Turku University Hospital
Phase 3 Unknown
NCT05392634 2022-05-31
MACS
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Unknown
NCT04939194 2021-06-25
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
Mansoura University
Phase 3 Unknown
NCT03664869 2021-04-01
FB10
Turku University Hospital
Phase 3 Unknown
NCT03296306 2017-09-28
FOCUS
Asan Medical Center
Phase 3 Unknown
NCT03193788 2017-06-21
PREMIER
Asan Medical Center
Phase 3 Unknown
NCT02951078 2016-11-01
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 3 Unknown
NCT01581723 2015-02-04
Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor
Chinese University of Hong Kong
Phase 3 Unknown
NCT02074189 2014-02-28
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer
Southwest Hospital, China
Phase 3 Unknown
NCT00553124 2014-01-10
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00553345 2014-01-10
Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00054626 2013-12-18
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003725 2013-11-06
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01094964 2013-08-12
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01542567 2012-05-22
DIC-2011
Carmel Medical Center
Phase 3 Unknown
NCT01087268 2011-07-15
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01082510 2011-03-24
Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)
Urological Oncology Council of Northern Tokyo
Phase 3 Unknown
NCT00146276 2006-09-27
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
Association of Urologic Oncology (AUO)
Phase 3 Unknown